These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 23842524)
1. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. Lavoie Smith EM; Li L; Hutchinson RJ; Ho R; Burnette WB; Wells E; Bridges C; Renbarger J Cancer Nurs; 2013; 36(5):E49-60. PubMed ID: 23842524 [TBL] [Abstract][Full Text] [Related]
2. Patterns and severity of vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia. Lavoie Smith EM; Li L; Chiang C; Thomas K; Hutchinson RJ; Wells EM; Ho RH; Skiles J; Chakraborty A; Bridges CM; Renbarger J J Peripher Nerv Syst; 2015 Mar; 20(1):37-46. PubMed ID: 25977177 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of vincristine-induced peripheral neuropathy in children with cancer: Turkish validity and reliability study. Özdemir B; Gerçeker GÖ; Özdemir EZ; Yildirim BG; Ören H; Yiş U; Günay Ç; Thomas GÖ J Pediatr Nurs; 2023; 72():185-190. PubMed ID: 37076371 [TBL] [Abstract][Full Text] [Related]
4. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia. Li T; Kandula T; Cohn RJ; Kiernan MC; Park SB; Farrar MA Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123 [TBL] [Abstract][Full Text] [Related]
5. RISK FACTORS OF VINCRISTINE-INDUCED PERIPHERAL NEUROPATHY IN ACUTE LYMPHOBLASTIC LEUKAEMIA CHILDREN. Tunjungsari DA; Gunawan PI; Ugrasena IDG J Med Invest; 2021; 68(3.4):232-237. PubMed ID: 34759136 [TBL] [Abstract][Full Text] [Related]
6. [A cohort study of vincristine-induced peripheral neuropathy in children]. Li C; Jin J; Huang J; Yang XY; Li Y; Yan YY; Yang C Zhongguo Dang Dai Er Ke Za Zhi; 2023 May; 25(5):470-475. PubMed ID: 37272172 [TBL] [Abstract][Full Text] [Related]
7. Vincristine-induced peripheral neuropathy in survivors of childhood acute lymphoblastic leukaemia. Tay CG; Lee VWM; Ong LC; Goh KJ; Ariffin H; Fong CY Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28139029 [TBL] [Abstract][Full Text] [Related]
8. Measuring vincristine-induced peripheral neuropathy in children with cancer: validation of the Dutch pediatric-modified Total Neuropathy Score. Schouten SM; van de Velde ME; Kaspers GJL; Mokkink LB; van der Sluis IM; van den Bos C; Hartman A; Abbink FCH; van den Berg MH Support Care Cancer; 2020 Jun; 28(6):2867-2873. PubMed ID: 31732853 [TBL] [Abstract][Full Text] [Related]
9. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia. Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658 [TBL] [Abstract][Full Text] [Related]
10. Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia. Egbelakin A; Ferguson MJ; MacGill EA; Lehmann AS; Topletz AR; Quinney SK; Li L; McCammack KC; Hall SD; Renbarger JL Pediatr Blood Cancer; 2011 Mar; 56(3):361-7. PubMed ID: 21225912 [TBL] [Abstract][Full Text] [Related]
11. Genetic Variants Associated With Vincristine-Induced Peripheral Neuropathy in Two Populations of Children With Acute Lymphoblastic Leukemia. Li L; Sajdyk T; Smith EML; Chang CW; Li C; Ho RH; Hutchinson R; Wells E; Skiles JL; Winick N; Martin PL; Renbarger JL Clin Pharmacol Ther; 2019 Jun; 105(6):1421-1428. PubMed ID: 30506673 [TBL] [Abstract][Full Text] [Related]
12. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy. Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238 [TBL] [Abstract][Full Text] [Related]
13. Assessment Tools for Peripheral Neuropathy in Pediatric Oncology: A Systematic Review From the Children's Oncology Group. Smolik S; Arland L; Hensley MA; Schissel D; Shepperd B; Thomas K; Rodgers C J Pediatr Oncol Nurs; 2018; 35(4):267-275. PubMed ID: 29566596 [TBL] [Abstract][Full Text] [Related]
14. Effect of pyridoxine plus pyridostigmine treatment on vincristine-induced peripheral neuropathy in pediatric patients with acute lymphoblastic leukemia: a single-center experience. Aydin Köker S; Gözmen S; Demirağ B; Ünalp A; Karapinar TH; Oymak Y; Gürbüz G; Öner Eİ; Vergin RC Neurol Sci; 2021 Sep; 42(9):3681-3686. PubMed ID: 33439396 [TBL] [Abstract][Full Text] [Related]
16. Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia. Lieber S; Blankenburg M; Apel K; Hirschfeld G; Hernáiz Driever P; Reindl T Eur J Paediatr Neurol; 2018 May; 22(3):457-469. PubMed ID: 29396168 [TBL] [Abstract][Full Text] [Related]
17. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. Chauvenet AR; Shashi V; Selsky C; Morgan E; Kurtzberg J; Bell B; J Pediatr Hematol Oncol; 2003 Apr; 25(4):316-20. PubMed ID: 12679647 [TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia. Karol SE; Sun Y; Tang L; Pui CH; Ferrolino J; Allison KJ; Cross SJ; Evans WE; Crews KR; Jeha S; Wolf J Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497 [TBL] [Abstract][Full Text] [Related]
19. Vincristine exposure in Kenyan children with cancer: CHAPATI feasibility study. Uittenboogaard A; van de Velde M; van de Heijden L; Mukuhi L; de Vries N; Langat S; Olbara G; Huitema ADR; Vik T; Kaspers G; Njuguna F Pediatr Blood Cancer; 2024 Sep; 71(9):e31160. PubMed ID: 38956809 [TBL] [Abstract][Full Text] [Related]
20. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia. Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067 [No Abstract] [Full Text] [Related] [Next] [New Search]